Clinical Research Trials

MOST

Multi-arm Optimization of Stroke Thrombolysis (MOST): a blinded, randomized controlled adaptive, multi-arm, adjunctive-thrombolysis efficacy trial in ischemic stroke.

The MOST study is designed to find out whether adding one of two blood thinning medicines to standard treatment helps decrease the impact of strokes and is safe.

Principal Investigator: Dr. Aniel Majjhoo

Contact: study coordinator

Phone (Main): 810-342-3067

IRB Number: 2019-05-006

Current Trial Type: NCT03735979

Status: open to enrollment